These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32743367)

  • 21. Radiation Recall Dermatitis in Patients Treated With Immune Checkpoint Inhibitors: A Case Report and Literature Review.
    Yigit E; Guven DC; Aksoy S; Yazici G
    Cureus; 2021 Jun; 13(6):e15548. PubMed ID: 34277173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nivolumab-Induced Organizing Pneumonia in Management of Non-small Cell Lung Carcinoma: A Case Report.
    Habib T; Abu-Abaa M; Kolman-Taddeo D
    Cureus; 2023 May; 15(5):e39217. PubMed ID: 37337505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two cases of delayed onset of immune-related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer.
    Nakai Y; Otsuka T; Inoue T; Nawa T; Hatano K; Yamamoto Y; Nagahara A; Nakayama M; Kakimoto KI; Nishimura K
    IJU Case Rep; 2021 Sep; 4(5):326-329. PubMed ID: 34497995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent Episodes of Nivolumab-Induced Pneumonitis after Nivolumab Discontinuation and the Time Course of Carcinoembryonic Antigen Levels: A Case of a 58-Year-Old Woman with Non-Small Cell Lung Cancer.
    de Jong C; Peters BJM; Schramel FMNH
    Chemotherapy; 2018; 63(5):272-277. PubMed ID: 30572331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granuloma-forming interstitial pneumonia induced by nivolumab: a possible immune-related adverse event of the lung.
    Kashiwada T; Saito Y; Minegishi Y; Kokuho N; Takahashi A; Takahashi S; Atsumi K; Seike M; Azuma A; Kubota K; Terasaki Y; Gemma A
    Int Cancer Conf J; 2017 Jul; 6(3):131-134. PubMed ID: 31149487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report.
    Mendiola VL; Kesireddy M; Jana B
    Case Rep Oncol Med; 2019; 2019():6759472. PubMed ID: 31949965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early onset recall pneumonitis during targeted therapy with sunitinib.
    Yuasa T; Kitsukawa S; Sukegawa G; Yamamoto S; Kudo K; Miyazawa K; Kozuka T; Harada S; Yonese J
    BMC Cancer; 2013 Jan; 13():3. PubMed ID: 23282195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature.
    Manapov F; Roengvoraphoj O; Dantes M; Marschner S; Li M; Eze C
    J Immunother; 2018; 41(2):96-99. PubMed ID: 29200082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy.
    Saito S; Abe T; Iino M; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Yamaguchi O; Kaira K; Kagamu H; Noda SE; Kato S
    J Radiat Res; 2021 Jul; 62(4):669-675. PubMed ID: 34121123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature.
    Chen Y; Huang Z; Xing L; Meng X; Yu J
    Front Oncol; 2020; 10():561. PubMed ID: 32411597
    [No Abstract]   [Full Text] [Related]  

  • 31. [A Case of Metachronous Occurrence of Interstitial Pneumonitis and Hypophysitis Following Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma].
    Hayase T; Washino S; Mayumi S; Yazaki K; Nakamura Y; Oshima M; Konishi T; Saito K; Miyagawa T
    Hinyokika Kiyo; 2021 Jun; 67(6):239-243. PubMed ID: 34265899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel.
    Schweitzer VG; Juillard GJ; Bajada CL; Parker RG
    Cancer; 1995 Sep; 76(6):1069-72. PubMed ID: 8625210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperprogressive disease after radiotherapy combined with anti-PD-1 therapy in renal cell carcinoma: a case report and review of the literature.
    Liu C; Piao J; Shang Z
    BMC Urol; 2021 Mar; 21(1):42. PubMed ID: 33743675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma.
    Nakajima N; Kano T; Oda K; Uchida T; Otaki T; Nagao K; Shimizu Y; Kawakami M; Kim H; Nitta M; Hasegawa M; Kawamura Y; Miyajima A
    IJU Case Rep; 2020 Sep; 3(5):215-218. PubMed ID: 32914080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Case of Suspected Radiation Recall Pneumonitis After a COVID-19 Infection.
    Kurosaki H; Utsumi N; Miura K
    Cureus; 2021 Mar; 13(3):e13688. PubMed ID: 33824832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation recall dermatitis after treatment of stage IV breast cancer with nivolumab: a case report.
    Billena C; Padia S; O'Brien B; Knoble J; Gokhale A; Rajagopalan M
    Immunotherapy; 2020 Feb; 12(2):123-130. PubMed ID: 31992119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report.
    Shibata Y; Noguchi G; Suzuki T; Osaka K; Umemoto S; Kishida T
    Am J Case Rep; 2021 Aug; 22():e932924. PubMed ID: 34358221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case of Long-Term Survival after Checkpoint Inhibitor Pneumonitis in a Patient with Squamous Cell Lung Cancer.
    Ashinuma H; Mizuno S; Yoshida Y; Shingyoji M
    Case Rep Oncol Med; 2019; 2019():4836404. PubMed ID: 31949964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease.
    Kanai O; Kim YH; Demura Y; Kanai M; Ito T; Fujita K; Yoshida H; Akai M; Mio T; Hirai T
    Thorac Cancer; 2018 Jul; 9(7):847-855. PubMed ID: 29782069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case of IgA Vasculitis During Nivolumab Therapy for Renal Cell Carcinoma.
    Nagaoka-Takatori A; Ishii M; Hayama K; Obinata D; Yamaguchi K; Takahashi S; Fujita H
    Clin Cosmet Investig Dermatol; 2021; 14():1885-1888. PubMed ID: 34992403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.